| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000002 | Mitochondrial genome maintenance | Decreases phenotype | PMID:27366949 |
| GO:0000084 | Mitotic s phase | Decreases phenotype | PMID:31730886 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Increases phenotype | PMID:31730886 |
| GO:0000122 | Negative regulation of transcription by rna polymerase ii | Increases phenotype | PMID:30077641 |
| GO:0001544 | Initiation of primordial ovarian follicle growth | Increases phenotype | PMID:36912754 |
| GO:0001586 | Gi/o-coupled serotonin receptor activity | Increases phenotype | PMID:29748632 |
| GO:0001654 | Eye development | Affects phenotype | PMID:31690747 |
| GO:0001659 | Temperature homeostasis | Decreases phenotype | PMID:26361728; PMID:26361728; PMID:26799708; PMID:26799708; PMID:28087785 |
| GO:0001661 | Conditioned taste aversion | Increases phenotype | PMID:27385208; PMID:30115766 |
| GO:0001662 | Behavioral fear response | Increases phenotype | PMID:27065006; PMID:29101333; PMID:34573260 |
| GO:0001774 | Microglial cell activation | Increases phenotype | PMID:26499171 |
| GO:0001825 | Blastocyst formation | Increases phenotype | PMID:31436397 |
| GO:0001890 | Placenta development | Affects phenotype | PMID:28578322; PMID:31953475 |
| GO:0002027 | Regulation of heart rate | Increases phenotype | PMID:10812285; PMID:19949319; PMID:484957; PMID:2829241; PMID:484957 |
| GO:0002032 | Desensitization of g protein-coupled receptor signaling pathway by arrestin | Increases phenotype | PMID:27429655 |
| GO:0002296 | T-helper 1 cell lineage commitment | Increases phenotype | PMID:27038180 |
| GO:0002507 | Tolerance induction | Affects phenotype | PMID:29461336 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:32612530; PMID:32872332 |
| GO:0002863 | Positive regulation of inflammatory response to antigenic stimulus | Increases phenotype | PMID:27038180 |
| GO:0003990 | Acetylcholinesterase activity | Increases phenotype | PMID:28212939 |
| GO:0004016 | Adenylate cyclase activity | Decreases phenotype | PMID:30319418 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:30130528 |
| GO:0004197 | Cysteine-type endopeptidase activity | Increases phenotype | PMID:31730886 |
| GO:0004392 | Heme oxygenase (decyclizing) activity | Decreases phenotype | PMID:32033040 |
| GO:0004565 | Beta-galactosidase activity | Decreases phenotype | PMID:32553926 |
| GO:0004707 | Map kinase activity | Increases phenotype | PMID:24184660 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:31680560 |
| GO:0005222 | Intracellular camp-activated cation channel activity | Affects phenotype | PMID:32329240 |
| GO:0005262 | Calcium channel activity | Increases phenotype | PMID:32733202 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:29549157 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:32272438 |
| GO:0006355 | Regulation of dna-templated transcription | Increases phenotype | PMID:29691375 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:24910342 |
| GO:0006536 | Glutamate metabolic process | Affects phenotype | PMID:30219209 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:32244040 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:29408467 |
| GO:0006665 | Sphingolipid metabolic process | Affects phenotype | PMID:27635674 |
| GO:0006692 | Prostanoid metabolic process | Affects phenotype | PMID:35588954 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:26070387; PMID:28212939; PMID:31680560 |
| GO:0006805 | Xenobiotic metabolic process | Affects phenotype | PMID:39299374 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:24910342; PMID:31383729; PMID:31680560; PMID:32272438; PMID:32872332 |
| GO:0006936 | Muscle contraction | Increases phenotype | PMID:30460515 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:26499171; PMID:30225659; PMID:32385136; PMID:32942172 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:31081965 |
| GO:0007015 | Actin filament organization | Affects phenotype | PMID:33477303 |
| GO:0007190 | Activation of adenylate cyclase activity | Increases phenotype | PMID:27194477 |
| GO:0007197 | Adenylate cyclase-inhibiting g protein-coupled acetylcholine receptor signaling pathway | Increases phenotype | PMID:27194477 |
| GO:0007268 | Chemical synaptic transmission | Decreases phenotype | PMID:12895676; PMID:32329240 |
| GO:0007605 | Sensory perception of sound | Decreases phenotype | PMID:27527584; PMID:31610187 |
| GO:0007610 | Behavior | Affects phenotype | PMID:30071445 |
| GO:0007613 | Memory | Decreases phenotype | PMID:27422357; PMID:28093016; PMID:33285233; PMID:28642081; PMID:28648819; PMID:28648819; PMID:30610611; PMID:30219209; PMID:30610611; PMID:31982904; PMID:33285233 |
| GO:0007616 | Long-term memory | Increases phenotype | PMID:28481360 |
| GO:0007625 | Grooming behavior | Affects phenotype | PMID:27126842; PMID:30071445 |
| GO:0007626 | Locomotory behavior | Decreases phenotype | PMID:27058925; PMID:32385136; PMID:27149200; PMID:27149200; PMID:28087785; PMID:31877572; PMID:31877572 |
| GO:0007632 | Visual behavior | Affects phenotype | PMID:31610187 |
| GO:0007635 | Chemosensory behavior | Increases phenotype | PMID:26388146; PMID:26397760; PMID:26875756 |
| GO:0008211 | Glucocorticoid metabolic process | Affects phenotype | PMID:36283465 |
| GO:0008219 | Cell death | Affects phenotype | PMID:24184660; PMID:31104297 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:32049991; PMID:32752303; PMID:32872332; PMID:35588954 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:30026298 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:26824325; PMID:27635674; PMID:27769052; PMID:29805589 |
| GO:0008306 | Associative learning | Increases phenotype | PMID:26397760; PMID:27149200; PMID:30694374; PMID:30965351 |
| GO:0008344 | Adult locomotory behavior | Decreases phenotype | PMID:30439379 |
| GO:0008360 | Regulation of cell shape | Affects phenotype | PMID:32049991 |
| GO:0008542 | Visual learning | Affects phenotype | PMID:28481360 |
| GO:0008559 | Abc-type xenobiotic transporter activity | Increases phenotype | PMID:28272498 |
| GO:0008653 | Lipopolysaccharide metabolic process | Affects phenotype | PMID:32754917 |
| GO:0009060 | Aerobic respiration | Decreases phenotype | PMID:31054322 |
| GO:0009408 | Response to heat | Decreases phenotype | PMID:28087785; PMID:28592614; PMID:31891265; PMID:32688070; PMID:32923660 |
| GO:0009410 | Response to xenobiotic stimulus | Increases phenotype | PMID:26460022; PMID:30378732 |
| GO:0009437 | Carnitine metabolic process | Affects phenotype | PMID:32872332 |
| GO:0010001 | Glial cell differentiation | Increases phenotype | PMID:32733202; PMID:36529297 |
| GO:0010033 | Response to organic substance | Affects phenotype | PMID:26361728; PMID:27149200 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Decreases phenotype | PMID:26044905; PMID:32272438; PMID:32704063; PMID:32704063; PMID:32994467; PMID:32994467 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:25674907; PMID:27635674 |
| GO:0010628 | Positive regulation of gene expression | Increases phenotype | PMID:28272498 |
| GO:0010719 | Negative regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:29805589 |
| GO:0010823 | Negative regulation of mitochondrion organization | Increases phenotype | PMID:27366949 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:27769052 |
| GO:0010942 | Positive regulation of cell death | Affects phenotype | PMID:26070387; PMID:27366949 |
| GO:0010977 | Negative regulation of neuron projection development | Increases phenotype | PMID:26460022 |
| GO:0014049 | Positive regulation of glutamate secretion | Increases phenotype | PMID:30151725 |
| GO:0014055 | Acetylcholine secretion, neurotransmission | Decreases phenotype | PMID:32077955 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:28212939; PMID:29181404; PMID:31081965; PMID:31680560 |
| GO:0016477 | Cell migration | Affects phenotype | PMID:28578322; PMID:29285308; PMID:31471547 |
| GO:0016525 | Negative regulation of angiogenesis | Increases phenotype | PMID:29307655; PMID:37567336 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:31081965 |
| GO:0019226 | Transmission of nerve impulse | Decreases phenotype | PMID:32077955 |
| GO:0019233 | Sensory perception of pain | Decreases phenotype | PMID:29311110 |
| GO:0019369 | Arachidonic acid metabolic process | Affects phenotype | PMID:33285233 |
| GO:0019432 | Triglyceride biosynthetic process | Decreases phenotype | PMID:30130528 |
| GO:0019852 | L-ascorbic acid metabolic process | Affects phenotype | PMID:32752303 |
| GO:0021872 | Forebrain generation of neurons | Decreases phenotype | PMID:29982505 |
| GO:0021895 | Cerebral cortex neuron differentiation | Decreases phenotype | PMID:26460022 |
| GO:0022848 | Acetylcholine-gated monoatomic cation-selective channel activity | Decreases phenotype | PMID:32077955 |
| GO:0023041 | Neuronal signal transduction | Increases phenotype | PMID:32095523; PMID:32353393; PMID:32725198 |
| GO:0023061 | Signal release | Increases phenotype | PMID:26824325 |
| GO:0030182 | Neuron differentiation | Increases phenotype | PMID:33168583 |
| GO:0030223 | Neutrophil differentiation | Increases phenotype | PMID:32272438 |
| GO:0030224 | Monocyte differentiation | Increases phenotype | PMID:32272438 |
| GO:0030317 | Flagellated sperm motility | Decreases phenotype | PMID:29454037 |
| GO:0030336 | Negative regulation of cell migration | Increases phenotype | PMID:29805589; PMID:33477303; PMID:37567336; PMID:37625625 |
| GO:0030431 | Sleep | Increases phenotype | PMID:30636988 |
| GO:0030851 | Granulocyte differentiation | Increases phenotype | PMID:32272438 |
| GO:0031175 | Neuron projection development | Decreases phenotype | PMID:27654887 |
| GO:0031223 | Auditory behavior | Decreases phenotype | PMID:28597570 |
| GO:0031324 | Negative regulation of cellular metabolic process | Increases phenotype | PMID:26824325 |
| GO:0031653 | Heat dissipation | Increases phenotype | PMID:27527584; PMID:28442584; PMID:31524960; PMID:31877572; PMID:32860777; PMID:28442584; PMID:28597570; PMID:28846955; PMID:31877572; PMID:31877572; PMID:32860777 |
| GO:0031987 | Locomotion involved in locomotory behavior | Increases phenotype | PMID:26499171; PMID:28093016; PMID:31311288; PMID:32353393; PMID:26984820; PMID:29750976; PMID:30610611; PMID:31029878; PMID:31110286; PMID:32095523; PMID:27065006; PMID:28272498; PMID:28648819; PMID:30610611; PMID:30965351; PMID:31029878; PMID:31524960; PMID:31524960; PMID:32209479; PMID:32345621; PMID:32860777; PMID:32095523; PMID:32209479; PMID:32353393; PMID:32860777 |
| GO:0032103 | Positive regulation of response to external stimulus | Decreases phenotype | PMID:27449567 |
| GO:0032148 | Activation of protein kinase b activity | Affects phenotype | PMID:26824325; PMID:27038180; PMID:29748632 |
| GO:0032967 | Positive regulation of collagen biosynthetic process | Increases phenotype | PMID:33352148 |
| GO:0032973 | Amino acid export across plasma membrane | Increases phenotype | PMID:27422357 |
| GO:0033555 | Multicellular organismal response to stress | Increases phenotype | PMID:27449567 |
| GO:0033603 | Positive regulation of dopamine secretion | Increases phenotype | PMID:30115766 |
| GO:0034067 | Protein localization to golgi apparatus | Decreases phenotype | PMID:27635674 |
| GO:0034109 | Homotypic cell-cell adhesion | Decreases phenotype | PMID:32049991 |
| GO:0034113 | Heterotypic cell-cell adhesion | Decreases phenotype | PMID:31154070 |
| GO:0034275 | Kynurenic acid metabolic process | Increases phenotype | PMID:30151725 |
| GO:0034394 | Protein localization to cell surface | Affects phenotype | PMID:33205494 |
| GO:0034505 | Tooth mineralization | Increases phenotype | PMID:33352148 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:26499171; PMID:28093016; PMID:29022873; PMID:33285233; PMID:27126842; PMID:28220044; PMID:29022873; PMID:29481316; PMID:31583843; PMID:29750976; PMID:31583843; PMID:33285233; PMID:33582152 |
| GO:0035249 | Synaptic transmission, glutamatergic | Affects phenotype | PMID:32329240 |
| GO:0035621 | Er to golgi ceramide transport | Decreases phenotype | PMID:27635674 |
| GO:0035640 | Exploration behavior | Increases phenotype | PMID:27065006; PMID:27126842; PMID:27449567; PMID:28402427; PMID:30538288; PMID:30538288; PMID:31311288; PMID:30610611; PMID:32773031 |
| GO:0035641 | Locomotory exploration behavior | Affects phenotype | PMID:31583843 |
| GO:0035810 | Positive regulation of urine volume | Increases phenotype | PMID:27231154 |
| GO:0035938 | Estradiol secretion | Increases phenotype | PMID:32647869 |
| GO:0036123 | Histone h3-k9 dimethylation | Increases phenotype | PMID:28976920; PMID:29022873; PMID:29481316 |
| GO:0036124 | Histone h3-k9 trimethylation | Increases phenotype | PMID:28481360; PMID:28976920; PMID:29022873; PMID:29481316; PMID:29481316 |
| GO:0036269 | Swimming behavior | Decreases phenotype | PMID:26499171; PMID:29982505 |
| GO:0036343 | Psychomotor behavior | Decreases phenotype | PMID:32923660 |
| GO:0040011 | Locomotion | Decreases phenotype | PMID:28905207 |
| GO:0042098 | T cell proliferation | Decreases phenotype | PMID:32942172 |
| GO:0042102 | Positive regulation of t cell proliferation | Increases phenotype | PMID:27268054 |
| GO:0042127 | Regulation of cell population proliferation | Affects phenotype | PMID:33352148 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:29181404 |
| GO:0042311 | Vasodilation | Increases phenotype | PMID:29181404 |
| GO:0042415 | Norepinephrine metabolic process | Affects phenotype | PMID:28212939 |
| GO:0042552 | Myelination | Increases phenotype | PMID:32956517 |
| GO:0042756 | Drinking behavior | Affects phenotype | PMID:29181404 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:25674907; PMID:27635674; PMID:33477303 |
| GO:0043149 | Stress fiber assembly | Affects phenotype | PMID:32049991 |
| GO:0043195 | Terminal bouton | Affects phenotype | PMID:30219209 |
| GO:0043197 | Dendritic spine | Increases phenotype | PMID:28481360 |
| GO:0043537 | Negative regulation of blood vessel endothelial cell migration | Increases phenotype | PMID:29307655 |
| GO:0043627 | Response to estrogen | Decreases phenotype | PMID:23494106 |
| GO:0043970 | Histone h3-k9 acetylation | Increases phenotype | PMID:28481360; PMID:28976920; PMID:29022873; PMID:29481316 |
| GO:0043977 | Histone h2a-k5 acetylation | Affects phenotype | PMID:28481360 |
| GO:0043983 | Histone h4-k12 acetylation | Affects phenotype | PMID:28481360 |
| GO:0044154 | Histone h3-k14 acetylation | Increases phenotype | PMID:28976920; PMID:29022873; PMID:29481316 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:27654887; PMID:28721267; PMID:28853159; PMID:29360751; PMID:29940172; PMID:29940172; PMID:30733293; PMID:30339727; PMID:30733293; PMID:31104297; PMID:32033040; PMID:32244040; PMID:32272438; PMID:32553926; PMID:32752303; PMID:36529297 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:31461164; PMID:32049991 |
| GO:0045333 | Cellular respiration | Affects phenotype | PMID:32872332 |
| GO:0045807 | Positive regulation of endocytosis | Increases phenotype | PMID:26733986 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Affects phenotype | PMID:31730886 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:31104297; PMID:32872332 |
| GO:0046058 | Camp metabolic process | Affects phenotype | PMID:16157695; PMID:27527584 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:29181404; PMID:31680560 |
| GO:0046323 | Glucose import | Affects phenotype | PMID:28219717 |
| GO:0046459 | Short-chain fatty acid metabolic process | Affects phenotype | PMID:32754917 |
| GO:0046697 | Decidualization | Increases phenotype | PMID:31154070 |
| GO:0046960 | Sensitization | Increases phenotype | PMID:28722246; PMID:29084627 |
| GO:0048041 | Focal adhesion assembly | Increases phenotype | PMID:31461164 |
| GO:0048143 | Astrocyte activation | Increases phenotype | PMID:31383729 |
| GO:0048148 | Behavioral response to cocaine | Increases phenotype | PMID:34436576 |
| GO:0048265 | Response to pain | Decreases phenotype | PMID:28722246; PMID:30965351 |
| GO:0048266 | Behavioral response to pain | Affects phenotype | PMID:26799708; PMID:27149200; PMID:27149200; PMID:27231154; PMID:27535976; PMID:28442584; PMID:28597570; PMID:32688070; PMID:32923660; PMID:27149200; PMID:28442584; PMID:27231154; PMID:27535976; PMID:30225659; PMID:31311288; PMID:31877572; PMID:32688070; PMID:32923660; PMID:32717503; PMID:32860777 |
| GO:0048469 | Cell maturation | Increases phenotype | PMID:32272438 |
| GO:0048666 | Neuron development | Decreases phenotype | PMID:36529297 |
| GO:0048709 | Oligodendrocyte differentiation | Increases phenotype | PMID:32956517 |
| GO:0048871 | Multicellular organismal homeostasis | Affects phenotype | PMID:27449567 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Increases phenotype | PMID:26633823 |
| GO:0050671 | Positive regulation of lymphocyte proliferation | Affects phenotype | PMID:27038180 |
| GO:0050795 | Regulation of behavior | Affects phenotype | PMID:29787777 |
| GO:0050870 | Positive regulation of t cell activation | Increases phenotype | PMID:27038180 |
| GO:0050879 | Multicellular organismal movement | Decreases phenotype | PMID:27449567 |
| GO:0050890 | Cognition | Increases phenotype | PMID:27422357; PMID:28402427; PMID:28481360; PMID:30538288; PMID:32329240 |
| GO:0050892 | Intestinal absorption | Increases phenotype | PMID:27648135 |
| GO:0050893 | Sensory processing | Decreases phenotype | PMID:28220044 |
| GO:0050894 | Determination of affect | Affects phenotype | PMID:26647971 |
| GO:0050975 | Sensory perception of touch | Affects phenotype | PMID:31610187 |
| GO:0051447 | Negative regulation of meiotic cell cycle | Decreases phenotype | PMID:28087314 |
| GO:0051490 | Negative regulation of filopodium assembly | Increases phenotype | PMID:37625625 |
| GO:0051726 | Regulation of cell cycle | Increases phenotype | PMID:27769052; PMID:33477303 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:32872332 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:27654887; PMID:31730886 |
| GO:0051932 | Synaptic transmission, gabaergic | Affects phenotype | PMID:32329240 |
| GO:0051971 | Positive regulation of transmission of nerve impulse | Increases phenotype | PMID:26388146 |
| GO:0060004 | Reflex | Decreases phenotype | PMID:28597570 |
| GO:0060021 | Roof of mouth development | Affects phenotype | PMID:31690747 |
| GO:0060081 | Membrane hyperpolarization | Increases phenotype | PMID:27421060 |
| GO:0060082 | Eye blink reflex | Decreases phenotype | PMID:27527584 |
| GO:0060134 | Prepulse inhibition | Affects phenotype | PMID:24776491; PMID:28272498; PMID:29748632 |
| GO:0060292 | Long-term synaptic depression | Increases phenotype | PMID:29038246 |
| GO:0060326 | Cell chemotaxis | Affects phenotype | PMID:27769052; PMID:28578322 |
| GO:0060715 | Syncytiotrophoblast cell differentiation involved in labyrinthine layer development | Decreases phenotype | PMID:26070387 |
| GO:0060719 | Chorionic trophoblast cell development | Decreases phenotype | PMID:26070387 |
| GO:0060997 | Dendritic spine morphogenesis | Affects phenotype | PMID:30283037 |
| GO:0061045 | Negative regulation of wound healing | Increases phenotype | PMID:37567336 |
| GO:0061366 | Behavioral response to chemical pain | Increases phenotype | PMID:29111112 |
| GO:0061367 | Behavioral response to acetic acid induced pain | Increases phenotype | PMID:19679411 |
| GO:0061368 | Behavioral response to formalin induced pain | Decreases phenotype | PMID:29461336; PMID:31891265 |
| GO:0061450 | Trophoblast cell migration | Decreases phenotype | PMID:31154070 |
| GO:0061527 | Dopamine secretion, neurotransmission | Increases phenotype | PMID:30151725 |
| GO:0061739 | Protein lipidation involved in autophagosome assembly | Increases phenotype | PMID:27769052 |
| GO:0061744 | Motor behavior | Affects phenotype | PMID:33068620 |
| GO:0061886 | Negative regulation of mini excitatory postsynaptic potential | Increases phenotype | PMID:27027565 |
| GO:0062072 | H3k9me3 modified histone binding | Increases phenotype | PMID:29481316 |
| GO:0070075 | Tear secretion | Decreases phenotype | PMID:32852544 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:32752303; PMID:36529297 |
| GO:0070633 | Transepithelial transport | Increases phenotype | PMID:27641813; PMID:27648135 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:28212939 |
| GO:0070997 | Neuron death | Decreases phenotype | PMID:27654887 |
| GO:0071625 | Vocalization behavior | Affects phenotype | PMID:31653479 |
| GO:0071674 | Mononuclear cell migration | Increases phenotype | PMID:32612530 |
| GO:0071926 | Endocannabinoid signaling pathway | Increases phenotype | PMID:36912754 |
| GO:0072518 | Rho-dependent protein serine/threonine kinase activity | Increases phenotype | PMID:29158718 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:26504004; PMID:32553926 |
| GO:0086001 | Cardiac muscle cell action potential | Affects phenotype | PMID:29181404 |
| GO:0090200 | Positive regulation of release of cytochrome c from mitochondria | Increases phenotype | PMID:27635674 |
| GO:0090327 | Negative regulation of locomotion involved in locomotory behavior | Increases phenotype | PMID:26361728; PMID:26799708; PMID:26875756 |
| GO:0090461 | Cellular glutamate homeostasis | Decreases phenotype | PMID:30151725 |
| GO:0090559 | Regulation of membrane permeability | Affects phenotype | PMID:27641813 |
| GO:0090648 | Response to environmental enrichment | Decreases phenotype | PMID:26499171; PMID:26499171; PMID:29022873; PMID:29481316; PMID:33285233; PMID:28648819; PMID:29022873; PMID:29481316; PMID:33285233 |
| GO:0090659 | Walking behavior | Decreases phenotype | PMID:27449567; PMID:35201352 |
| GO:0097202 | Activation of cysteine-type endopeptidase activity | Increases phenotype | PMID:35588954 |
| GO:0097214 | Positive regulation of lysosomal membrane permeability | Increases phenotype | PMID:27635674 |
| GO:0097237 | Cellular response to toxic substance | Affects phenotype | PMID:23494106 |
| GO:0097336 | Response to risperidone | Decreases phenotype | PMID:28272498 |
| GO:0097410 | Hippocampal interneuron differentiation | Decreases phenotype | PMID:26976041 |
| GO:0097498 | Endothelial tube lumen extension | Decreases phenotype | PMID:29307655 |
| GO:0098532 | Histone h3-k27 trimethylation | Decreases phenotype | PMID:28976920 |
| GO:0098817 | Evoked excitatory postsynaptic potential | Decreases phenotype | PMID:26732435 |
| GO:0098908 | Regulation of neuronal action potential | Affects phenotype | PMID:33168583 |
| GO:0140059 | Dendrite arborization | Affects phenotype | PMID:30283037 |
| GO:0140131 | Positive regulation of lymphocyte chemotaxis | Increases phenotype | PMID:27038180 |
| GO:0150033 | Negative regulation of protein localization to lysosome | Increases phenotype | PMID:27635674 |
| GO:1900272 | Negative regulation of long-term synaptic potentiation | Increases phenotype | PMID:26732435; PMID:29982505 |
| GO:1900273 | Positive regulation of long-term synaptic potentiation | Increases phenotype | PMID:29982505 |
| GO:1900453 | Negative regulation of long-term synaptic depression | Increases phenotype | PMID:29982505 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Increases phenotype | PMID:29454037 |
| GO:1901380 | Negative regulation of potassium ion transmembrane transport | Increases phenotype | PMID:27027565 |
| GO:1901856 | Negative regulation of cellular respiration | Decreases phenotype | PMID:27826249 |
| GO:1902306 | Negative regulation of sodium ion transmembrane transport | Increases phenotype | PMID:27027565 |
| GO:1903295 | Negative regulation of glutamate secretion, neurotransmission | Increases phenotype | PMID:26732435 |
| GO:1903296 | Positive regulation of glutamate secretion, neurotransmission | Increases phenotype | PMID:30151725 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:26070387; PMID:27366949 |
| GO:1903626 | Positive regulation of dna catabolic process | Increases phenotype | PMID:27769052 |
| GO:1903860 | Negative regulation of dendrite extension | Increases phenotype | PMID:29982505 |
| GO:1903980 | Positive regulation of microglial cell activation | Increases phenotype | PMID:26819091 |
| GO:1904000 | Positive regulation of eating behavior | Increases phenotype | PMID:23072421 |
| GO:1904053 | Positive regulation of protein targeting to vacuole involved in autophagy | Increases phenotype | PMID:27635674 |
| GO:1904057 | Negative regulation of sensory perception of pain | Increases phenotype | PMID:26824325 |
| GO:1904094 | Positive regulation of autophagic cell death | Increases phenotype | PMID:27635674 |
| GO:1904426 | Positive regulation of gtp binding | Increases phenotype | PMID:26361728; PMID:27535976 |
| GO:1904439 | Negative regulation of iron ion import across plasma membrane | Increases phenotype | PMID:27681840 |
| GO:1904456 | Negative regulation of neuronal action potential | Increases phenotype | PMID:27027565 |
| GO:1904457 | Positive regulation of neuronal action potential | Increases phenotype | PMID:30151725 |
| GO:1904646 | Cellular response to amyloid-beta | Decreases phenotype | PMID:31104297 |
| GO:1904972 | Negative regulation of viral translation | Increases phenotype | PMID:26733986 |
| GO:1905447 | Negative regulation of mitochondrial atp synthesis coupled electron transport | Increases phenotype | PMID:31054322 |
| GO:1905563 | Negative regulation of vascular endothelial cell proliferation | Increases phenotype | PMID:29307655 |
| GO:1905665 | Positive regulation of calcium ion import across plasma membrane | Increases phenotype | PMID:29658714 |
| GO:1905790 | Regulation of mechanosensory behavior | Affects phenotype | PMID:27449567 |
| GO:1905955 | Negative regulation of endothelial tube morphogenesis | Increases phenotype | PMID:29307655 |
| GO:1990138 | Neuron projection extension | Decreases phenotype | PMID:31917333 |
| GO:1990349 | Gap junction-mediated intercellular transport | Increases phenotype | PMID:28087314 |
| GO:1990708 | Conditioned place preference | Decreases phenotype | PMID:28951549; PMID:30115766; PMID:32095523 |
| GO:1990926 | Short-term synaptic potentiation | Decreases phenotype | PMID:28402427 |
| GO:1990962 | Xenobiotic transport across blood-brain barrier | Increases phenotype | PMID:28272498 |
| GO:2000252 | Negative regulation of feeding behavior | Increases phenotype | PMID:26633823; PMID:27126842 |
| GO:2000330 | Positive regulation of t-helper 17 cell lineage commitment | Increases phenotype | PMID:27038180 |
| GO:2000355 | Negative regulation of ovarian follicle development | Increases phenotype | PMID:36912754 |
| GO:2000854 | Positive regulation of corticosterone secretion | Increases phenotype | PMID:30071445; PMID:30115766 |
| GO:2000986 | Negative regulation of behavioral fear response | Increases phenotype | PMID:26799708 |
| GO:2000987 | Positive regulation of behavioral fear response | Affects phenotype | PMID:26799708; PMID:30115766 |
| GO:2001023 | Regulation of response to drug | Affects phenotype | PMID:27449567 |
| GO:2001024 | Negative regulation of response to drug | Affects phenotype | PMID:27231154 |
| GO:2001025 | Positive regulation of response to drug | Increases phenotype | PMID:24776491; PMID:27065006; PMID:27635674 |
| GO:2001171 | Positive regulation of atp biosynthetic process | Increases phenotype | PMID:26070387 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.